Nobuyuki Arakawa
President & CEO @ Celaid Therapeutics
About
I have currently been into the healthcare and life science field and experienced business development and management. As I am a President & CEO and co-founder of Celaid Therapeutics founded in 2020, we aim to develop new cell therapy to help patients with blood cancers and immunodeficiencies all over the world using our innovative technology. We hope our product and technology will help a lot of patients in the future. Before bio-tech field, I have experienced a lot as a business consultant and involved in several projects of business strategy, supply chain, business development and so on in the industries of healthcare, electronics, manufacturing, retail and IT.
Japan
Tokyo
Biotechnology
Strategy, Business Development, Project Management, Supply Chain Management, AI, IT Strategy, Change Management, Analysis, Business Process Re-engineering, Finance, Start-up, Medical Device, Business Consulting, IoT, Applied Physics, Regenerative Medicine, Stem Cell, Biotech
Experience

President
Rescrea
日本 東京
IT & Management Consulting - AI / IoT, Software service, Healthcare, Manufacturing, Financial industry, Retail

General Manager
Amnos
東京都
Biotech company to utilize dehydrated fetal human amniotic membrane for regenerative bio materials

General Manager
TSS
日本 東京
Manufacturing company to provide automated assembly equipment to produce electronic components.
Nobuyuki Arakawa's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.




